Adverse reactions due to directly observed treatment strategy therapy in Chinese tuberculosis patients: a prospective study.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMC 3672195)

Published in PLoS One on June 04, 2013

Authors

Xiaozhen Lv1, Shaowen Tang, Yinyin Xia, Xiaomeng Wang, Yanli Yuan, Daiyu Hu, Feiying Liu, Shanshan Wu, Yuan Zhang, Zhirong Yang, Dehua Tu, Yixin Chen, Peiyuan Deng, Yu Ma, Ru Chen, Siyan Zhan

Author Affiliations

1: Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, China.

Articles cited by this

Adverse drug reactions: definitions, diagnosis, and management. Lancet (2000) 16.12

Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med (2003) 7.40

The effect of tuberculosis control in China. Lancet (2004) 4.84

An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health (2004) 3.28

Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care (2004) 2.77

Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis. Eur Respir J (1996) 2.18

Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding. Int J Tuberc Lung Dis (2010) 2.02

Frequency and type of reactions to antituberculosis drugs: observations in routine treatment. Tuber Lung Dis (1996) 1.70

Anti-tuberculosis medication side-effects constitute major factor for poor adherence to tuberculosis treatment. Bull World Health Organ (2008) 1.66

Adverse drug reactions associated with first-line anti-tuberculosis drug regimens. Int J Tuberc Lung Dis (2007) 1.28

Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China. PLoS One (2011) 1.18

Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 1: first-line drugs. J Bras Pneumol (2010) 1.16

Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis. Respir Med (2006) 1.15

[Adverse effects of the new tuberculosis treatment regimen recommended by the Brazilian Ministry of Health]. J Bras Pneumol (2010) 1.13

Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil. Eur J Clin Pharmacol (2008) 1.08

Study of adverse drug reactions caused by first line anti-tubercular drugs used in directly observed treatment, short course (DOTS) therapy in Western Nepal, Pokhara. J Pak Med Assoc (2008) 0.99

[Systematic review of anti-tuberculosis drug induced adverse reactions in China]. Zhonghua Jie He He Hu Xi Za Zhi (2007) 0.96

Design of the anti-tuberculosis drugs induced adverse reactions in China National Tuberculosis Prevention and Control Scheme Study (ADACS). BMC Public Health (2010) 0.94

Evaluation of anti-tuberculosis induced adverse reactions in hospitalized patients. Pharm Pract (Granada) (2006) 0.94

Adverse reactions of anti-tuberculosis drugs in hospitalized patients: incidence, severity and risk factors. Pharmacoepidemiol Drug Saf (2007) 0.94

Adverse drug reactions observed during DOTS. J Commun Dis (2004) 0.92

Adverse effects of tuberculosis treatment: experience at an outpatient clinic of a teaching hospital in the city of São Paulo, Brazil. J Bras Pneumol (2008) 0.90

Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid. Hepatology (1995) 0.86

Clinical evaluation and monitoring of adverse effects for fixed multidose combination against single drug therapy in pulmonary tuberculosis patients. Pak J Pharm Sci (2008) 0.83

Adverse effects of antituberculosis drugs causing changes in treatment. Tubercle (1982) 0.80

Avoidance and management of adverse reactions to antituberculosis drugs. Drug Saf (1995) 0.78

Articles by these authors

Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature (2004) 24.40

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. Am J Respir Crit Care Med (2015) 6.03

Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol (2011) 3.97

Genomic analyses identify distinct patterns of selection in domesticated pigs and Tibetan wild boars. Nat Genet (2013) 3.41

Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan Province, China: discovery of a new bunyavirus. PLoS Pathog (2011) 2.95

CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells. Cancer Res (2006) 2.92

Building statistical models to analyze species distributions. Ecol Appl (2006) 2.42

Identification of Younger Dryas outburst flood path from Lake Agassiz to the Arctic Ocean. Nature (2010) 2.29

Mass spectrometry based targeted protein quantification: methods and applications. J Proteome Res (2009) 2.20

Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise. CMAJ (2013) 1.86

Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis. Mol Endocrinol (2008) 1.85

In Vivo 3D Digital Atlas Database of the Adult C57BL/6J Mouse Brain by Magnetic Resonance Microscopy. Front Neuroanat (2008) 1.85

Disruption of nesprin-1 produces an Emery Dreifuss muscular dystrophy-like phenotype in mice. Hum Mol Genet (2008) 1.83

Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions. Proc Natl Acad Sci U S A (2007) 1.82

Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study. Mol Ther (2005) 1.81

Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest (2002) 1.80

Outcomes of congenital diaphragmatic hernia in the modern era of management. J Pediatr (2013) 1.80

Proteomic identification of exosomal LRG1: a potential urinary biomarker for detecting NSCLC. Electrophoresis (2011) 1.75

Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism. PLoS Med (2006) 1.73

Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands. J Biol Chem (2006) 1.72

Protein kinase Cbeta inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy. J Am Soc Nephrol (2005) 1.67

Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. BMC Med Genet (2009) 1.66

Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007. J Virol (2007) 1.65

Mast cell infiltration and chemokine expression in progressive renal disease. Kidney Int (2003) 1.61

Structure and interactions of plant cell-wall polysaccharides by two- and three-dimensional magic-angle-spinning solid-state NMR. Biochemistry (2011) 1.57

Mass spectrometry based glycoproteomics--from a proteomics perspective. Mol Cell Proteomics (2010) 1.55

Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum Mol Genet (2009) 1.54

An acute experimental model demonstrating 2 different forms of sustained atrial tachyarrhythmias. Circ Arrhythm Electrophysiol (2009) 1.54

ECM1 controls T(H)2 cell egress from lymph nodes through re-expression of S1P(1). Nat Immunol (2011) 1.54

Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients. Mol Ther (2005) 1.53

Structural, electrical, and optical properties of Ti-doped ZnO films fabricated by atomic layer deposition. Nanoscale Res Lett (2013) 1.50

Renal expression and localization of the facilitative glucose transporters GLUT1 and GLUT12 in animal models of hypertension and diabetic nephropathy. Am J Physiol Renal Physiol (2005) 1.48

Nesprin-1 mutations in human and murine cardiomyopathy. J Mol Cell Cardiol (2009) 1.48

Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells. Cell Res (2011) 1.47

Liver X receptor alpha is a transcriptional repressor of the uncoupling protein 1 gene and the brown fat phenotype. Mol Cell Biol (2008) 1.47

Direct repair of displaced anterior arch fracture of the atlas under microendoscopy: experience with seven patients. Eur Spine J (2011) 1.46

Liver X receptors regulate adrenal cholesterol balance. J Clin Invest (2006) 1.45

Differential responses of infectious diseases to economic growth in China. Int J Infect Dis (2011) 1.45

Membrane protein structure and dynamics from NMR spectroscopy. Annu Rev Phys Chem (2011) 1.43

Change of extracellular glutamate and gamma-aminobutyric acid in substantia nigra and globus pallidus during electrical stimulation of subthalamic nucleus in epileptic rats. Stereotact Funct Neurosurg (2008) 1.43

Anatomy and physiology of the right interganglionic nerve: implications for the pathophysiology of inappropriate sinus tachycardia. J Cardiovasc Electrophysiol (2008) 1.42

Retracted Open reduction and closed reduction internal fixation in treatment of femoral neck fractures: a meta-analysis. BMC Musculoskelet Disord (2014) 1.42

B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer. Clin Immunol (2008) 1.42

SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages. J Biol Chem (2009) 1.39

Characterization of rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis isolated in China. Tuberculosis (Edinb) (2002) 1.37

Total phenolic contents and antioxidant capacities of selected chinese medicinal plants. Int J Mol Sci (2010) 1.35

Identification and functional characterization of paxillin as a target of protein tyrosine phosphatase receptor T. Proc Natl Acad Sci U S A (2010) 1.30

Type 2 diabetes mellitus in China: a preventable economic burden. Am J Manag Care (2009) 1.30

IGFBP7 plays a potential tumor suppressor role in colorectal carcinogenesis. Cancer Biol Ther (2007) 1.30

Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism. J Biol Chem (2008) 1.29

Performance of detecting IgM antibodies against enterovirus 71 for early diagnosis. PLoS One (2010) 1.28

Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis. J Gen Virol (2006) 1.28

Visible-light photoredox catalysis in flow. Angew Chem Int Ed Engl (2012) 1.28

Delivery of telomerase reverse transcriptase small interfering RNA in complex with positively charged single-walled carbon nanotubes suppresses tumor growth. Clin Cancer Res (2006) 1.28

Comparison on genomic predictions using three GBLUP methods and two single-step blending methods in the Nordic Holstein population. Genet Sel Evol (2012) 1.27

Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor gamma-dependent pathway. Circulation (2006) 1.26

Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling. J Proteome Res (2011) 1.25

Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysis. PLoS One (2013) 1.25

Generation of haploid embryonic stem cells from Macaca fascicularis monkey parthenotes. Cell Res (2013) 1.24

Adapting a generic tuberculosis control operational guideline and scaling it up in China: a qualitative case study. BMC Public Health (2008) 1.23

Novel double-antigen sandwich immunoassay for human hepatitis B core antibody. Clin Vaccine Immunol (2010) 1.22

Expression, localization, and function of the thioredoxin system in diabetic nephropathy. J Am Soc Nephrol (2009) 1.22

Messenger RNA as a source of transposase for sleeping beauty transposon-mediated correction of hereditary tyrosinemia type I. Mol Ther (2007) 1.21

Ground tit genome reveals avian adaptation to living at high altitudes in the Tibetan plateau. Nat Commun (2013) 1.20

Arousal of cancer-associated stroma: overexpression of palladin activates fibroblasts to promote tumor invasion. PLoS One (2012) 1.20

Optical and microstructural properties of ZnO/TiO2 nanolaminates prepared by atomic layer deposition. Nanoscale Res Lett (2013) 1.19

Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China. PLoS One (2011) 1.18

Cyanomethanaminium tetra-fluoro-borate. Acta Crystallogr Sect E Struct Rep Online (2010) 1.17

Polycyclic aromatic hydrocarbons (PAHs) in urban soils of the megacity Shanghai: occurrence, source apportionment and potential human health risk. Sci Total Environ (2013) 1.17

Identifying Drug (Cocaine) Intake Events from Acute Physiological Response in the Presence of Free-living Physical Activity. IPSN (2014) 1.17

Inhibition of protein kinase C-beta by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy. Circ Heart Fail (2009) 1.16

Strong, conductive, lightweight, neat graphene aerogel fibers with aligned pores. ACS Nano (2012) 1.16

Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice. Cancer Sci (2010) 1.16

Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression. J Immunol (2011) 1.15

Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension. Diabetes (2003) 1.15

Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells. Cancer Immunol Immunother (2008) 1.15

High-efficiency polymer solar cells enhanced by solvent treatment. Adv Mater (2013) 1.14

Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism. PLoS One (2010) 1.13

Nuclear receptors HNF4α and LRH-1 cooperate in regulating Cyp7a1 in vivo. J Biol Chem (2012) 1.13

Overexpression of thymic stromal lymphopoietin in allergic rhinitis. Acta Otolaryngol (2009) 1.13

Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy. Nephrology (Carlton) (2011) 1.12

How do type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China? Value Health (2009) 1.12

Stk40 links the pluripotency factor Oct4 to the Erk/MAPK pathway and controls extraembryonic endoderm differentiation. Proc Natl Acad Sci U S A (2010) 1.12

2-Butyl-1,3-diphenyl-2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazine. Acta Crystallogr Sect E Struct Rep Online (2008) 1.12

IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis with its expression associated with DNA hypomethylation of exon 1. J Zhejiang Univ Sci B (2006) 1.12

Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment. Int J Cancer (2014) 1.12

Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer. Lung Cancer (2006) 1.11